Janney Montgomery Scott’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$306K Buy
+7,390
New +$297K ﹤0.01% 2729
2024
Q4
– Sell
-12,435
Closed -$359K – 2751
2024
Q3
$359K Sell
12,435
-5,348
-30% -$153K ﹤0.01% 2182
2024
Q2
$484K Sell
17,783
-18,981
-52% -$508K ﹤0.01% 1916
2024
Q1
$1.03M Buy
+36,764
New +$1.01M ﹤0.01% 1509
2023
Q2
– Sell
-10,574
Closed -$276K – 2663
2023
Q1
$276K Sell
10,574
-107
-1% -$2.87K ﹤0.01% 2100
2022
Q4
$293K Buy
10,681
+305
+3% +$8.12K ﹤0.01% 2146
2022
Q3
$249K Buy
+10,376
New +$268K ﹤0.01% 2140

Other funds holding FTXH

Janney Montgomery Scott's FTXH Position: Q3 2026 in Review

Janney Montgomery Scott opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 7,390 shares worth $306K. The stake represents ﹤0.01% of the portfolio and ranks #2729 among its holdings. This is a return to the name: Janney Montgomery Scott previously reported a position in FTXH as recently as Q3 2024.

Janney Montgomery Scott first reported a position in FTXH in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.03M in Q1 2024. 71 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.

  • Janney Montgomery Scott held 7,390 shares of First Trust Nasdaq Pharmaceuticals ETF worth $306K as of Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF was a new Janney Montgomery Scott position in Q3 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q3 2026, its #2729 holding.
  • Janney Montgomery Scott first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2022 and has held it in 7 quarters since.
  • Janney Montgomery Scott's First Trust Nasdaq Pharmaceuticals ETF position peaked at $1.03M in Q1 2024.
  • 71 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.

Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.